Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Prospective multi-center phase 2b randomized placebo-controlled double-blinded interventional
platform trial of two different pharmacologic therapies (intravenous Vitamin C or intravenous
Acetaminophen) for patients with sepsis-induced hypotension or respiratory failure.